[NAM Members:  to register and for link to full program email the Membership Office]

National Academy of Sciences Building
2101 Constitution Avenue, NW – Washington, DC  20418

 Monday, October 15, 2018
(All events with exception of lunch to be held in Fred Kavli Auditorium.)

6:45 a.m.8:00 a.m.

8:00 a.m.8:40 a.m.                       
President’s Report to the NAM Membership
Victor J. Dzau, M.D., NAM President

8:40 a.m.9:00 a.m.   
Victor J. Dzau, M.D.
     Class of 2017 NAM Members
     2018-2019 Robert Wood Johnson Foundation Health Policy Fellows
     2018-2019 NAM/AAN/ANA/ANF Distinguished Nurse Scholar-in-Residence
     2018-2019 FDA Tobacco Regulatory Science Fellows
     2018-2020 NAM Fellows
     2018-2020 International Fellows 
     2018-2019 Emerging Leaders in Health and Medicine              

9:00 a.m.9:30 a.m.
Awards Presentations
The Gustav O. Lienhard Award  Glenn D. Steele, Jr., M.D., Ph.D., Chairman, GSteele Health Solutions   The Rhoda and Bernard Sarnat International Prize in Mental Health 
        Margarita Alegria, Ph.D., Professor of Psychology, Departments of Medicine & Psychiatry, Harvard
        Medical School
The NAM Member Awards
  Jane E. Henney, M.D., Home Secretary, National Academy of Medicine
The Cecil Awards
  J. Michael McGinnis, M.D., The Leonard D. Schaeffer Executive Officer

Cancers: Can We Beat the Odds?
(Note:  Individual Talk Titles Are Subject to Change)

9:30 a.m.9:45 a.m. 
Welcome and Introduction by the Program Chair
Story C. Landis, Ph.D., Scientist Emeritus, National Institute of Neurological Disorders and Stroke

9:45 a.m.10:15 a.m.
Keynote Address

Laurie H. Glimcher, M.D., President & CEO, Dana-Farber Cancer Institute

10:15 a.m.10:45 a.m.

10:45 a.m.12:00 p.m.
Cancer Prevention:  Promise and Unrealized Potential—Half of All Cancers Could Be Prevented, Why Aren’t They?

Moderator:  Otis W. Brawley, M.D., M.A.C.P., Chief Medical Officer, American Cancer Society, Professor 
     of Hematology, Medical Oncology, Medicine, and Epidemiology, Emory University
Targeting Cancer with Precision Prevention
Ernie Hawk, M.D., M.P.H., Vice President and Head, Division of Cancer Prevention and Population
     Sciences, T. Boone Pickens Distinguished Chair for Early Prevention of Cancer, The University of
     Texas MD Anderson Cancer Center 
How Much Cancer Risk is Inherited? Implications and Value of Germline Genetic Testing
Kenneth Offit, M.D., M.P.H., Chief, Clinical Genetics Service, Department of Medicine; and Member, Cancer
     Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center
The Role of Vaccination in Cancer Prevention. Focus on HPV and Cervical Cancer: A Preventable Cancer that is on the Rise Globally
Douglas R. Lowy, M.D., Deputy Director, National Cancer Institute, National Institutes of Health
New Strategies to Prevent Cancer by Addressing Common Risk Factors: Focus on Obesity and Cancer
Cornelia Ulrich, M.S., Ph.D., Senior Director, Huntsman Cancer Institute 

12:00 p.m. –1:30 p.m.              

1:30 p.m.2:45 p.m.  
The Biology of Cancers:  Challenges for Therapeutics
Moderator:  Levi A. Garraway, M.D., Ph.D., Senior Vice President Global Development and Medical
    Affairs, Oncology, Eli Lilly and Company 
Tumor Heterogeneity and Tumor Evolution
Kornelia Polyak, M.D., Ph.D., Professor of Medicine, Dana-Farber Cancer Institute, Harvard Medical School
Getting Ahead of Resistance 
Kevan M. Shokat, Ph.D., Professor of Cellular and Molecular Pharmacology, Department of Cellular 
     and Molecular Pharmacology, University of California, San Francisco
Overcoming Resistance to Molecularly Targeted Cancer Therapy 

Charles Sawyers, M.D., 
Investigator, Howard Hughes Medical Institute; Marie-Josée and Henry Kravis
     Chair in Human Oncology and Pathogenesis and Chairman, Human Oncology & Pathogenesis
     Program, Memorial Sloan Kettering Cancer Center
Resistance to Immune Therapy
Antoni Ribas, M.D., Ph.D., 
Professor of Medicine, Professor of Surgery, Professor of Molecular and Medical 
     Pharmacology, University of California Los Angele

2:45 p.m.4:00 p.m. 
Fighting Cancers:  From Biology to Policy
Moderator:  Mary C. Beckerle, Ph.D., 
Jon M. Huntsman Presidential Endowed Chair, CEO and Director,
     Huntsman Cancer Institute; and Associate Vice President of Cancer Affairs, University of Utah
The Promise of Sequencing in Patient Care 
Elaine R. Mardis, Ph.D., 
Professor of Pediatrics, Co-Executive Director, Institute for Genomic Medicine,
     Nationwide Children’s Hospital

CAR-T as Curative Therapy for All B Cell Malignancies 
Carl June, M.D., 
Richard W. Vague Professor in Immunotherapy, Department of Pathology and Laboratory 
Director, Center for Cellular Immunotherapies,and Director, Parker Institute for Cancer
     Immunotherapy, University of Pennsylvania School of Medicine

Cancer Treatment and Financing: Commercial Payer Perspective
Lee Newcomer, M.D., M.H.A. 
Economics of Cancer Care: Cost and Value of Anti-Cancer Therapies 
Peter B. Bach, M.D., MAPP, Director, Center for Health Policy and Outcomes, Department of Epidemiology 
     & Biostatistics, Memorial Sloan-Kettering Cancer Center

4:00 p.m.4:15 p.m. 
Concluding Remarks by the Program Chair
Story C. Landis, Ph.D., Scientist Emeritus, National Institute of Neurological Disorders and Stroke

4:15 p.m.5:45 p.m.  
President’s Forum:  Affordable Medicines: Access, Innovation, and the Public Interest
Victor J. Dzau, M.D., President, National Academy of Medicine

5:45 p.m.5:50 p.m.  

5:50-p.m.7:30 p.m. 



Outlook Outlook
iCal iCal
Google Google
Yahoo! Yahoo!